CFC launches multi-class policy for medical device market

BioSurance MD is a multi-class policy targeting key exposures for a wide range of medical device companies involved with the design, development, manufacture or distribution of medical devices of all grades.

Andrew Tamworth, head of life sciences at CFC, said: “This is a unique industry with some very specific exposures and products that can literally mean the difference between life and death.

"Whether making anaesthetic machines or syringes, dentures or stents, these companies need specialist